Literature DB >> 16239182

Poststroke dementia.

Didier Leys1, Hilde Hénon, Marie-Anne Mackowiak-Cordoliani, Florence Pasquier.   

Abstract

Dementia is one of the major causes of dependency after stroke. The prevalence of poststroke dementia (PSD)-defined as any dementia occurring after stroke-is likely to increase in the future. In community-based studies, the prevalence of PSD in stroke survivors is about 30% and the incidence of new onset dementia after stroke increases from 7% after 1 year 48% after 25 years. Having a stroke doubles the risk of dementia. Patient-related variables associated with an increased risk of PSD are increasing age, low education level, dependency before stroke, prestroke cognitive decline without dementia, diabetes mellitus, atrial fibrillation, myocardial infarction, epileptic seizures, sepsis, cardiac arrhythmias, congestive heart failure, silent cerebral infarcts, global and medial-temporal-lobe atrophy, and white-matter changes. Stroke-related variables associated with an increased risk of PSD are stroke severity, cause, location, and recurrence. PSD might be the result of vascular lesions, Alzheimer pathology, white-matter changes, or combinations of these. The cause of PSD differs among studies in relation to the mean age of patients, ethnicity, criteria used, and time after stroke. In developed countries, the proportion of patients with presumed Alzheimer's disease among those with PSD is between 19% and 61%. Patients with PSD have high mortality rates and are likely to be functionally impaired. These patients should be treated according to the current guidelines for stroke prevention.

Entities:  

Mesh:

Year:  2005        PMID: 16239182     DOI: 10.1016/S1474-4422(05)70221-0

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  175 in total

1.  Dementia: poststroke dementia--an underestimated burden?

Authors:  Sandra Black
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

2.  Early biomarkers for post-stroke cognitive impairment.

Authors:  Lai Qian; Lidong Ding; Liqun Cheng; Xiaolei Zhu; Hui Zhao; Jiali Jin; Dening Guan; Bing Zhang; Xuemei Chen; Yun Xu
Journal:  J Neurol       Date:  2012-03-10       Impact factor: 4.849

3.  Cerebrovascular lesions induce transient β-amyloid deposition.

Authors:  Monica Garcia-Alloza; Julia Gregory; Kishore V Kuchibhotla; Sara Fine; Ying Wei; Cenk Ayata; Matthew P Frosch; Steven M Greenberg; Brian J Bacskai
Journal:  Brain       Date:  2011-11-26       Impact factor: 13.501

4.  Changes in memory before and after stroke differ by age and sex, but not by race.

Authors:  Qianyi Wang; Iván Mejía-Guevara; Pamela M Rist; Stefan Walter; Benjamin D Capistrant; M Maria Glymour
Journal:  Cerebrovasc Dis       Date:  2014-03-25       Impact factor: 2.762

5.  Psychosis post corona radiata and lentiform nucleus infarction.

Authors:  Khadijah Hasanah Abang Abdullah; Suriati Mohamed Saini; Shalisah Sharip; Abdul Hamid Abdul Rahman
Journal:  BMJ Case Rep       Date:  2015-04-02

Review 6.  Interventions for heart disease and their effects on Alzheimer's disease.

Authors:  Benjamin Wolozin; Martin M Bednar
Journal:  Neurol Res       Date:  2006-09       Impact factor: 2.448

Review 7.  Vascular disease and cognitive impairment.

Authors:  Christiane Reitz; José A Luchsinger; Richard Mayeux
Journal:  Expert Rev Neurother       Date:  2008-08       Impact factor: 4.618

8.  Docosahexaenoic acid confers enduring neuroprotection in experimental stroke.

Authors:  Sung-Ha Hong; Ludmila Belayev; Larissa Khoutorova; Andre Obenaus; Nicolas G Bazan
Journal:  J Neurol Sci       Date:  2013-12-31       Impact factor: 3.181

Review 9.  Statins and dementia.

Authors:  Lewis H Kuller
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

Review 10.  The impact of cerebrovascular aging on vascular cognitive impairment and dementia.

Authors:  Tuo Yang; Yang Sun; Zhengyu Lu; Rehana K Leak; Feng Zhang
Journal:  Ageing Res Rev       Date:  2016-09-28       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.